title: In vivo effects of naproxen, salicylic acid, and valproic acid on the pharmacokinetics of trichloroethylene and metabolites in rats.
abstract: It was recently demonstrated that some drugs modulate in vitro metabolism of trichloroethylene (TCE) in humans and rats. The objective was to assess in vivo interactions between TCE and three drugs: naproxen (NA), valproic acid (VA), and salicylic acid (SA). Animals were exposed to TCE by inhalation (50 ppm for 6 h) and administered a bolus dose of drug by gavage, equivalent to 10-fold greater than the recommended daily dose. Samples of blood, urine, and collected tissues were analyzed by headspace gas chromatography coupled to an electron capture detector for TCE and metabolites (trichloroethanol [TCOH] and trichloroacetate [TCA]) levels. Coexposure to NA and TCE significantly increased (up to 50%) total and free TCOH (TCOHtotal and TCOHfree, respectively) in blood. This modulation may be explained by an inhibition of glucuronidation. VA significantly elevated TCE levels in blood (up to 50%) with a marked effect on TCOHtotal excretion in urine but not in blood. In contrast, SA produced an increase in TCOHtotal levels in blood at 30, 60, and 90 min and urine after coexposure. Data confirm in vitro observations that NA, VA, and SA affect in vivo TCE kinetics. Future efforts need to be directed to evaluate whether populations chronically medicated with the considered drugs display greater health risks related to TCE exposure.
authors.affiliation: a Sciences Biologiques , Université du Québec à Montréal , Montréal , Quebec , Canada.
authors.forename: Mouna Cheikh
authors.initials: MC
authors.lastname: Rouhou
authors.forename: Ginette
authors.initials: G
authors.lastname: Charest-Tardif
authors.forename: Sami
authors.initials: S
authors.lastname: Haddad
mesh_terms: D000700:Analgesics / Q000378:metabolism; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000378:metabolism; D000927:Anticonvulsants / Q000378:metabolism; D005023:Ethylene Chlorohydrin / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism / Q000493:pharmacokinetics / Q000652:urine; D008297:Male; D008962:Models, Theoretical; D009288:Naproxen / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D018570:Risk Assessment; D020156:Salicylic Acid / Q000378:metabolism*; D012997:Solvents / Q000378:metabolism* / Q000493:pharmacokinetics; D014238:Trichloroacetic Acid / Q000097:blood / Q000378:metabolism* / Q000493:pharmacokinetics / Q000652:urine; D014241:Trichloroethylene / Q000097:blood / Q000378:metabolism* / Q000493:pharmacokinetics / Q000652:urine; D014635:Valproic Acid / Q000378:metabolism*
chemical_list: D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000927:Anticonvulsants; D012997:Solvents; D014241:Trichloroethylene; D009288:Naproxen; D014238:Trichloroacetic Acid; D014635:Valproic Acid; D005023:Ethylene Chlorohydrin; C005849:2,2,2-trichloroethanol; D020156:Salicylic Acid